Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.
Chong CY, Jalali A, Wong HL, Loft M, Wong R, Lee M, Gately L, Hong W, Shapiro J, Kosmider S, Tie J, Ananda S, Yeung JM, Ma B, Burge M, Jennens R, Tran B, Lee B, Lim L, Dean A, Nott L, Gibbs P. Chong CY, et al. Among authors: dean a. Asia Pac J Clin Oncol. 2022 Oct;18(5):e363-e368. doi: 10.1111/ajco.13728. Epub 2022 Jan 24. Asia Pac J Clin Oncol. 2022. PMID: 35073441
Previous Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry.
Burge M, Semira C, Lee B, Lee M, Kosmider S, Wong R, Shapiro J, Ma B, Dean AP, Zimet AS, Steel SA, Lok SW, Torres J, Eastgate M, Wong HL, Gibbs P. Burge M, et al. Among authors: dean ap. Clin Colorectal Cancer. 2018 Sep;17(3):e593-e599. doi: 10.1016/j.clcc.2018.05.009. Epub 2018 Jun 1. Clin Colorectal Cancer. 2018. PMID: 29958812
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status.
Travers A, Jalali A, Begbie S, Semira C, Kosmider S, Ananda S, Wong R, Lee M, Shapiro J, Burge M, Yip D, Torres J, Ma B, Nott L, Dean A, Tie J, Khattak A, Lim S, Wong HL, Gibbs P. Travers A, et al. Among authors: dean a. Clin Colorectal Cancer. 2021 Mar;20(1):e21-e34. doi: 10.1016/j.clcc.2020.08.002. Epub 2020 Aug 12. Clin Colorectal Cancer. 2021. PMID: 32919889
Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population.
Min ST, Roohullah A, Tognela A, Jalali A, Lee M, Wong R, Shapiro J, Burge M, Yip D, Nott L, Zimet A, Lee B, Dean A, Steel S, Wong HL, Gibbs P, Lim SH. Min ST, et al. Among authors: dean a. Asia Pac J Clin Oncol. 2022 Apr;18(2):e56-e63. doi: 10.1111/ajco.13553. Epub 2021 Apr 18. Asia Pac J Clin Oncol. 2022. PMID: 33870631
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases.
Mathai VK, Aung SY, Wong V, Dunn C, Shapiro J, Jalali A, Wong R, Lee M, Tie J, Ananda S, Kosmider S, Lim SH, Caird S, Burge M, Dean A, Gibbs P, Nott L. Mathai VK, et al. Among authors: dean a. Clin Colorectal Cancer. 2021 Dec;20(4):e233-e239. doi: 10.1016/j.clcc.2021.06.003. Epub 2021 Jun 25. Clin Colorectal Cancer. 2021. PMID: 34289941
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.
Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Banerjee S, García-Donas J, Swisher EM, Cameron T, Maloney L, Goble S, Coleman RL. Ledermann JA, et al. Among authors: dean a. Lancet Oncol. 2020 May;21(5):710-722. doi: 10.1016/S1470-2045(20)30061-9. Lancet Oncol. 2020. PMID: 32359490 Free PMC article.
Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib.
Kwan TT, Oza AM, Tinker AV, Ray-Coquard I, Oaknin A, Aghajanian C, Lorusso D, Colombo N, Dean A, Weberpals J, Severson E, Vo LT, Goble S, Maloney L, Harding T, Kaufmann SH, Ledermann JA, Coleman RL, McNeish IA, Lin KK, Swisher EM. Kwan TT, et al. Among authors: dean a. JAMA Oncol. 2021 Dec 1;7(12):1772-1781. doi: 10.1001/jamaoncol.2021.4664. JAMA Oncol. 2021. PMID: 34647981 Free PMC article.
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
1,220 results